Progressive Care
Schedules Investor Conference Call
for May
15th, 2018
MIAMI,
FL -- May 10, 2018 -- InvestorsHub NewsWire
-- Progressive Care Inc.
(OTC.QB:
RXMD), a healthcare services and technology
company, is pleased to
announce that the Company has scheduled
an investor conference call at 4:30 PM ET
on
Tuesday,
May
15th,
2018.
It's been a
very eventful and very successful three months,"
stated S.
Parikh Mars, CEO. "We respect the
importance of open communication, and enjoy keeping investors up to
date on Company developments through these ongoing quarterly
calls."
On the
call, S. Parikh Mars,
Progressive Care Inc. CEO,
will
address:
- An
overview of the Company's Q1 2018 financial results
- Company and industry
trends and developments
- Status updates on
2018 initiatives
In
addition, interested parties
have the opportunity to submit questions concerning the Company
prior to the call to Stuart Smith at SmallCapVoice.Com, Inc. via
email: ssmith@smallcapvoice.com
by 3:00 PM eastern
standard time on Monday,
May,
14th,
2018.
Mr. Smith will compile a list of questions and submit them
to the Company
prior to
the conference call. Which questions
will be
addressed will be based on the
relevance
to the shareholder base, and the question's
appropriateness in light of public disclosure rules.
To access the
call:
Dial-In Number:
1-857-232-0157
Access
Code: 422095
For those
unable to participate in the live conference call, a replay will be
available at https://smallcapvoice.com/blog/rxmd/
shortly
after the call has concluded. An archived version of the webcast
will also be available https://progressivecareus.com/investor/.
Get
connected and stay in touch with us on social media:
Progressive
Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo,
LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive
Care
Progressive
Care Inc. (RXMD), through its PharmCo, LLC, is a South Florida
health services organization and provider of prescription
pharmaceuticals, compounded medications, provider of tele-pharmacy
services, the sale of anti-retroviral medications, medication
therapy management (MTM), the supply of prescription medications to
long term care facilities, and health practice risk
management.
Cautionary
Statement Regarding Forward Looking Statements
Statements
contained herein that are not based upon current or historical fact
are forward-looking in nature and constitute forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934.
Such forward-looking statements reflect the Company's expectations
about its future operating results, performance and opportunities
that involve substantial risks and uncertainties. These statements
include but are not limited to statements regarding the intended
terms of the offering, closing of the offering and use of any
proceeds from the offering. When used herein, the words
"anticipate," "believe," "estimate," "upcoming," "plan," "target,"
"intend" and "expect" and similar expressions, as they relate to
Progressive Care Inc., its subsidiaries, or its management, are
intended to identify such forward-looking statements. These
forward-looking statements are based on information currently
available to the Company and are subject to a number of risks,
uncertainties, and other factors that could cause the Company's
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Contact
Armen
Karapetyan
Senior
Advisor Business Development
armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
For
SmallCapVoice.com, Inc.
Stuart
T. Smith
512-267-2430
ssmith@smallcapvoice.com